Provention bio investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of provention bio, inc. - prvb

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of provention bio, inc. (nasdaqgs: prvb) to sanofi (nasdaqgs: sny). under the terms of the proposed transaction, shareholders of provention will receive only $25.00 in cash for each share of provention that they own.
PRVB Ratings Summary
PRVB Quant Ranking